Valuation: Medinotec Inc.

Market Cap 58.67M 52.66M 48.62M 44.09M 82.4M 5.57B 83.42M 583M 232M 2.92B 220M 216M 9.26B P/E 2025
27.2x
P/E 2026 74x
Enterprise Value 55.93M 50.19M 46.35M 42.03M 78.55M 5.31B 79.52M 556M 221M 2.78B 210M 205M 8.83B EV / Sales 2025
6,241,228x
EV / Sales 2026 5,748,224x
Free-Float
15.57%
Yield 2025 *
-
Yield 2026 -
3 years 5
Extreme 5
5
5 years 5
Extreme 5
5
10 years 5
Extreme 5
5
Manager TitleAgeSince
Chief Executive Officer 47 2021-04-25
Director of Finance/CFO 40 2021-04-25
Director TitleAgeSince
Chairman 47 -
Director/Board Member 55 2022-06-12
Director/Board Member 69 2022-06-12
Date Insider Type Main position Quantity % Market Cap. Importance
4/16/25 Other

Director

12,073 0.1029%
4/16/25 Other

Director

0 0%
4/16/25 Other

Chief Financial Officer

401,965 3.4257%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 58.67M
-1.75%+0.65%-18.92%+11.06% 181B
-1.53%-0.72%-21.24%+15.39% 117B
-0.88%-0.46%+0.06%+35.66% 116B
+3.89%+20.80%-42.56%+8.20% 89.94B
-0.94%-4.55%-2.50%+74.61% 62.97B
+1.00%+3.09%+14.65%+83.00% 55.43B
-0.63%+0.84%+4.48%-22.33% 53.49B
-1.41%+1.17%-12.81%+44.23% 44.92B
-0.66%+3.26%-4.83%-8.81% 33.87B
Average -0.25%+3.17%-8.37%+24.10% 75.56B
Weighted average by Cap. -0.45%+3.30%-12.69%+24.46%

Financials

2025 2026
Net sales 9.11 8.18 7.55 6.85 12.8 865.66 12.96 90.55 35.96 453.74 34.21 33.48 1.44K 9.73 8.73 8.06 7.31 13.67 924.15 13.83 96.67 38.39 484.4 36.52 35.74 1.54K
Net income 2.16M 1.94M 1.79M 1.62M 3.03M 205M 3.07M 21.46M 8.52M 108M 8.11M 7.93M 341M 795K 713K 658K 597K 1.12M 75.47M 1.13M 7.89M 3.14M 39.56M 2.98M 2.92M 125M
Net Debt -1.79M -1.61M -1.48M -1.34M -2.51M -170M -2.54M -17.77M -7.06M -89.05M -6.71M -6.57M -282M -2.74M -2.46M -2.27M -2.06M -3.85M -260M -3.9M -27.24M -10.82M -136M -10.29M -10.07M -433M
Projected Income Statement - Annual - Medinotec Inc.
Logo Medinotec Inc.
Medinotec Inc., through its primary investment in DISA Medinotec Proprietary Limited, is engaged in medical device manufacturing and distribution. The Company’s segments include Sales Outside the United States and Domestic Sales. The Sales Outside the United States segment includes both internally developed products and third-party products distributed under agreement. The Domestic Sales segment focuses on the proprietary Trachealator product within the United States. The Company manufactures and distributes medical devices that focus on tracheal non-occlusive airway dilatation technology. Its products include Trachealator, Cape Cross PTCA Catheter, Cape Cross Non-Compliant Catheter, Aortic Valve Dilatation Balloon Catheter, and Micro CTO Catheter. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.
Employees
36
  1. Stock Market
  2. Stocks
  3. MDNC Stock